Nanobac Pharmaceuticals, Incorporated (NNBP)

USD 0.0

(0.0%)

Market Cap (In USD)

24.95 Thousand

Revenue (In USD)

17.62 Thousand

Net Income (In USD)

-6.57 Million

Avg. Volume

6153.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-6-1.0E-4
PE
-
EPS
-
Beta Value
-35.702
ISIN
US63007M1027
CUSIP
63007M102
CIK
-
Shares
249507000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. John M. Stanton
Employee Count
-
Website
-
Ipo Date
1994-10-31
Details
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.